Bicara Therapeutics Inc. · NASDAQ:BCAX
Hyep Ivan sold 12,500 Bicara Therapeutics Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Hyep Ivan (Chief Financial Officer) sold 12,500 Bicara Therapeutics Inc. shares at US$27.97 for US$350K under a trading plan, leaving 129,855 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 12,500 shares
- Price
- US$27.97
- Value
- US$350K
- Holding after
- 129,855 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Option exercise | 12,500 | US$3.79 | 142,355 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 12,500 | US$27.97 | 129,855 | Direct |
Source
Related
- Bicara Therapeutics Inc.
- Hyep Ivan
- Bicara Therapeutics Inc. shareholders
- Form 4 · Hyep Ivan · Jul 10, 2026
- Form 4 · Hyep Ivan · May 26, 2026
- Form 4 · Hyep Ivan · Apr 22, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026
- Form 4 · Cohlhepp Ryan · Aug 12, 2026